EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieKlinische Studie (Phase III)Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Fluid/function correlation using AI ‐based quantification versus central subfield thickness in treatment‐naïve and pre‐treated patients with neovascular AMD in a real‐world setting

Anna Eidenberger iD, Gregor S Reiter iD, Virginia Mares, Sophie Frank-Publig iD, Philipp Fuchs iD, Magdalena Baratsits, Markus Gumpinger, Georg Faustmann, Alexandra Miere, Catherine Creuzot-Garcher iD, Ulrike Scheschy, Laurent Kodjikian und 4 weitere

Acta Ophthalmologica · 2025

DOI: 10.1111/aos.70000 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Acta Ophthalmologica, 2025. Verfasst von Anna Eidenberger und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: Wet Macular Degeneration, Visual Acuity, Subretinal Fluid, Tomography, Optical Coherence. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To investigate the association between best‐corrected visual acuity (BCVA) and quantitative macular fluid volumes, compared to central subfield thickness (CST) in treatment‐naïve and previously treated patients with active neovascular age‐related macular degeneration (nAMD). Methods and Analysis Baseline data were collected from 290 eyes of 290 participants consecutively enrolled in a prospective, randomized phase III clinical trial. Intraretinal fluid (IRF), subretinal fluid (SRF) and pigment epithelial detachment (PED) volumes were quantified and localized using an MDR‐certified AI algorithm (Fluid Monitor, RetInSight). Fluid volumes and CST were included in linear regression models for comparison.

Results

Significantly greater IRF volumes within each macular region were observed in treatment‐naïve patients, whereas larger PED volumes contributed to higher CST values in pretreated patients. In both subgroups, the largest proportion of BCVA variance could be explained by measuring IRF and SRF volumes within the entire 6‐mm area (adjusted R 2 = 0.140 and 0.225, respectively). In pre‐treated eyes, CST explained only half as much BCVA variance as the 6‐mm fluid model, and the model's fit was even poorer when compared to the CST model in the treatment‐naïve subgroup (adjusted R 2 = 0.078 vs. 0.198).

Conclusion

The examination of IRF and SRF volumes significantly impacts BCVA in nAMD. The weaker association of CST highlights its limitations as a parameter of disease activity. These findings emphasize the necessity of distinct fluid volume quantification as a relevant surrogate for visual function loss or benefit in nAMD, with particular emphasis on treatment duration and fluid in regions beyond the central 1‐mm.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Wet Macular DegenerationVisual AcuitySubretinal FluidTomography, Optical CoherenceMacula LuteaArtificial IntelligenceHumansFemaleMaleProspective StudiesAgedAngiogenesis InhibitorsIntravitreal InjectionsFluorescein AngiographyFollow-Up StudiesAged, 80 and overFundus OculiRanibizumabMiddle AgedVascular Endothelial Growth Factor AAlgorithms

Stichwörter der Autor:innen

anti‐VEGFartificial intelligencebiomarkermachine learningneovascular AMDoptical coherence tomographyretina

Substanzen

Angiogenesis InhibitorsRanibizumabVascular Endothelial Growth Factor A

Autor:innen und Institutionen

  • Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria.
  • Laboratory for Ophthalmic Image Analysis (OPTIMA), Medical University of Vienna, Vienna, Austria.
  • Institute of Artificial Intelligence, Center of Medical Data Science, Medical University of Vienna, Vienna, Austria.
  • Department of Ophthalmology, Intercity Hospital of Créteil, University Paris-Est Créteil, Créteil, France.
  • Department of Ophthalmology, Dijon University Hospital, Dijon, France.
  • Department of Ophthalmology, Horn Regional Hospital, Horn, Austria.

ORCID-Profile: Anna Eidenberger, Gregor S Reiter, Sophie Frank-Publig, Philipp Fuchs, Catherine Creuzot-Garcher, Benjamin Wolff, Stefan Sacu, Ursula Schmidt-Erfurth

Zitieren

APA

Eidenberger, A., Reiter, G. S., Mares, V., Frank-Publig, S., Fuchs, P., Baratsits, M., Gumpinger, M., Faustmann, G., Miere, A., Creuzot-Garcher, C., Scheschy, U., Kodjikian, L., Gualino, V., Wolff, B., Sacu, S., & Schmidt-Erfurth, U. (2025). Fluid/function correlation using AI ‐based quantification versus central subfield thickness in treatment‐naïve and pre‐treated patients with neovascular AMD in a real‐world setting. Acta Ophthalmologica. https://doi.org/10.1111/aos.70000

Vancouver

Eidenberger A, Reiter GS, Mares V, Frank-Publig S, Fuchs P, Baratsits M, et al. Fluid/function correlation using AI ‐based quantification versus central subfield thickness in treatment‐naïve and pre‐treated patients with neovascular AMD in a real‐world setting. Acta Ophthalmologica. 2025. doi:10.1111/aos.70000

BibTeX
@article{Eidenberger2025,
  author = {Eidenberger, Anna and Reiter, Gregor S and Mares, Virginia and Frank-Publig, Sophie and Fuchs, Philipp and Baratsits, Magdalena and Gumpinger, Markus and Faustmann, Georg and Miere, Alexandra and Creuzot-Garcher, Catherine and Scheschy, Ulrike and Kodjikian, Laurent and Gualino, Vincent and Wolff, Benjamin and Sacu, Stefan and Schmidt-Erfurth, Ursula},
  title = {Fluid/function correlation using AI ‐based quantification versus central subfield thickness in treatment‐naïve and pre‐treated patients with neovascular AMD in a real‐world setting},
  journal = {Acta Ophthalmologica},
  year = {2025},
  doi = {10.1111/aos.70000}
}
Kostenlos starten →